ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 157,67
-0,05%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) Actualités

TXG 10x Genomics Inc

20,20
0,48 (2,43%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
10x Genomics Inc TXG NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,48 2,43% 20,20 06:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,61 19,34 20,295 20,25 19,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202422:08EDGAR2Form 8-K - Current report
06/6/202422:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:05PRNUS10x Genomics Launches 5,000-Plex Gene Panel for Xenium
24/5/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/5/202422:23EDGAR2Form 144 - Report of proposed sale of securities
22/5/202422:17EDGAR2Form 144 - Report of proposed sale of securities
02/5/202422:05PRNUS10x Genomics to Present at the BofA Securities 2024..
30/4/202422:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
10/4/202422:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
26/3/202414:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
21/3/202421:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
13/3/202421:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
06/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:40EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202401:19EDGAR2Form 144 - Report of proposed sale of securities
23/2/202401:06EDGAR2Form 144 - Report of proposed sale of securities
23/2/202400:59EDGAR2Form 144 - Report of proposed sale of securities
20/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05PRNUS10x Genomics to Present at the 44th Annual TD Cowen Health..
15/2/202423:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202423:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:05EDGAR2Form 8-K - Current report
15/2/202422:05PRNUS10x Genomics Reports Fourth Quarter and Full Year 2023..
13/2/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:05PRNUS10x Genomics Expands Leadership in Single Cell Analysis with..
05/2/202422:05PRNUS10x Genomics to Showcase New Cutting-Edge Technologies and..
24/1/202422:05PRNUS10x Genomics to Report Fourth Quarter and Full Year 2023..
18/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:08EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:07EDGAR2Form 8-K - Current report
08/1/202415:00EDGAR2Form 8-K - Current report
08/1/202415:00PRNUS10x Genomics Announces Preliminary Fourth Quarter and Full..
29/12/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:05PRNUS10x Genomics to Present at the 42nd Annual J.P. Morgan..
20/12/202322:05PRNUS10x Genomics Launches Xenium Catalyst Network
19/12/202315:00PRNUSIntegrative Study Conducted by 10x Genomics Combines Single..
18/12/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:09EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:26PRNUSHigh Sensitivity and Specificity of the Xenium Platform from..
07/12/202315:00PRNUS10x Genomics and NIH CARD to Create Comprehensive Single..
28/11/202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
TXG
10x Genomics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés